Table 4.

Pooled estimates of metabolic syndrome based on sex/gender.

Study/Year	Sample size (male)	Sample size (female)	P% male by NCEP/ATP III	P% female by NCEP/ATP III	P% male by IDF	P% female by IDF
Berhan et al. [57]/2012	109	204	17.4	23	—	—
Mossie et al. [36]/2016	620	696	6	14.5	11.1	21.7
Tachebele et al. [37]/2014	115	185	12	28.7	9.3	30.3
Tadewos et al. [58]/2018	105	133	37.9	62.1	—	—
Bosho et al. [38]/2018	57	211	21	24.2	—	—
Hirigo et al. [39]/2016	68	117	17.6	17.9	8.8	33.3
Tran et al. [40]/2011	1171	764	10	16.2	—	—
Abda et al. [60]/2016	106	119	16	35.3	14	24
Tadewos et al. [61]/2017	166	104	36.7	60.6	—	—
Tesfaye et al. [41]/2014	126	248	18.3	16.1	15.1	28.2
Biadgo et al. [42]/2018	64	95	56.3	73.7	—	—
Birarra et al. [43]/2018	113	143	33.9	66.1	27.4	72.6
Solomon et al. [44]/2020	155	170	18.1	22.4	1.9	14.7
Gebremeskel et al. [45]/2019	208	211	—	—	42.5	57.5
Gebremariam et al. [47]/2020	823	557	—	—	41.1	40.2
Asaye et al. [48]/2020	229	131	11.4	17.5	—	—
Wube et al. [49]/2019	211	103	69.7	70.9	32.7	94.2
Teshome et al. [50]/2020	143	102	46.7	53.3	47	53
Zerga et al. [62]/2020	170	160	—	—	—	—
Gebreyes et al. [51]/2018	1306	7367	—	—	8.6	1.8
KerieS et al. [52]/2019	271	263	6.6	12.5	—	—
Gebrehiwot et al. [53]/2020	124	142	—	—	18.5	24.6
Cheneke et al. [63]/2019	—	365	−202	27.7	—	—
Geto et al. [56]/2018	232	218	19.4	13.8	35.8	18.8
Combined pooled estimate (95% CI: LCI, UCI)	24.82% (95% CI: 18.34, 31.31)	34.09% (95% CI: 26.68, 41.50)	22.22% (95% CI: 14.89, 29.56)	36.74% (95% CI: 20.72, 52.75)

NCEP/ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; IDF, International Diabetes Federation; LCI, lower confidence interval; UCI, upper confidence interval.